Blutspende Zürich | Allgemein

Wissenschaftliche Publikationen


2013	MATRIX-ASSISTED LASER DESORPTION/IONISATION, TIME-OF-FLIGHT MASS SPECTROMETRY-BASED BLOOD GROUP GENOTYPING - THE ALTERNATIVE APPROACH C. Gassner, S. Meyer, B.M. Frey, C. Vollmert	Transfusion Medicine Reviews 27 (2013) 2-9

2012	A RARE KEL02.17 / KEL02N.06(IVS3+1g>a) COMPOUND HETEROZYGOUS INDIVIDUAL, PRONE TO ANTI-KEL11 IMMUNIZATION S. Meyer, S. Sigurdardottir, C. Engström, A. Zorbas-Nikos, B.M. Frey, C. Gassner	45. Jahreskongress DGTI 11.-14. Sep. 2012 Graz

	HÄUFIGKEIT UND VERLAUF VON ANTI-HLA KLASSE I UND KLASSE II ANTIKÖRPERN BEI 1552 THROMBOZYTAPHERESE-SPENDERN E. Meyer, C. Brönnimann, Y. Merki, C. Gassner, B.M. Freyr	45. Jahreskongress DGTI 11.-14. Sep. 2012 Graz

	MEASURES TO PREVENT TRANSFUSION-RELATED ACUTE LUNG INJURY (TRALI)H.W. Reesink, J. Lee, A. Keller, P. Dennington, J. Pink, R. Holdsworth, H. Schennach, M. Goldman, T. Petraszko, J. Sun, Y. Meng, K. Qian, V. Rehacek, ^P. Turek, T. Krusius, E. Juvonen, P. Tiberghien, D. Legrand, G. Semana, J.Y. Muller, J. Bux, A. Reil, C.K. Lin, H. Daly, E. McSweeney, L. Porretti, N. Greppi, P. Rebulla, H. Okazaki, S.A. Sanchez-Guerrero, H.A. Baptista-Gonzales, C. Martinez-Murillo, A. Guerra-Marquez, H. Rodriguez-Moyado, R.A. Middelburg, J.C. Wiersum-Osselton, A. Brand, C. van Tilburg, D. Dinesh, J. Dagger, P. Dunn, E. Brojer, M. Letowska, K. Maslanka, E. Lachert, M. Uhrynowska, E. Zhiburt, M. Palfi, G. Berlin, B.M. Frey, L. Puig Rovira, E. Muniz-Diaz, E. Castro, C. Chapman, A. Green, E. Massey, N. Win, L. Williamson, C.C. Silliman, D.J. Chaffin, D.R. Ambruso, N. Blumberg, P. Tomasulo, K.J. Land, P.J. Norris, O.C. Illoh, R.J. Davey, R.J. Benjamin, A.F. Eder, L. McLaughlin, S. Kleinman, S. Panzer	Vox Sanguinis (2012) 103, 231-259

	PRESENCE OF DEL261G (O1) AND 803C (B) ON ONE HYBRID ALLELE - A POTENTIAL CAUSE FOR MISINTERPRETATION OF PCR-SSP RESULTS S. Meyer, S. Sigurdardottir, K. Neuenschwander, B.M. Frey, C. Gassner	SVTM Jahreskongress 2012 6.-7. Sep. 2012 Basel

	APPLICATION OF STATISTICAL PROCESS CONTROL (SPC) IN QUALITY CONTROL MONITORING OF BLOOD PRODUCTS A. Glauser, E. Meyer, B.M. Frey	SVTM Jahreskongress 2012 6.-7. Sep. 2012 Basel

	WHOLE BLOOD FILTER RZ-EFFICIENTLY LEUKODEPLETES POOLED PLASMA PRIOR TO PATHOGEN INACTIVATION WITH INTERCEPT D. Goslings, A. Valek, B.M. Frey	32nd Regional Congress of the ISBT 9-12 July, 2012 Cancun

	A NAT ONLY HBV POSITIVE DONATION: BREAKTHROUGH SUBCLINICAL INFECTION IN A HBV VACCINATED BLOOD DONOR J. Gottschalk, A. Glauser, K. Hardegger, B.M. Frey	32nd Regional Congress of the ISBT 9-12 July, 2012 Cancun

2011	REPORT ON A HIGH-THROUGHPUT BLOOD GROUP GENOTYPING PROTOTYPE USING MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY (MALDI-TOF MS) C. Gassner, B.M. Frey, C. Vollmer	Transfusion 2011-Vol. 51, Supplement

	DNA-ALIGNMENT DRIVEN JAK2 EXON 12 MUTATION ANALYSIS DEFINES 2 BROAD GENETIC MUTANT "CLUSTERS" AND SIMPLIFIES GENETIC TESTING BY PCR-SSP C. Gassner, S. Sigurdardottir, E. Meyer, B.M. Frey	44. Jahreskongress DGTI 27.-30. Sep. 2011 Hannover

	FLEXIBLE ORGANIZATION OF THE INTERCEPT PATHOGEN INACTIVATION PROCESS FOR PLATELETS OMITS EXTENSION OF PRODUCT SHELF-LIFE A. Valek, D. Goslings, A. Röthlisberger, G. Yavuzcan, B.M. Frey	44. Jahreskongress DGTI 27.-30. Sep. 2011 Hannover

	DISSECTION OF THE X-CHROMOSOMAL MCLEOD LOCUS AND DIRECT GENE SEQUENCING AS TOOLS FOR THE ANALYSIS OF KX GENE DELETIONS AND MUTATIONS E. Meyer, M. Fragnière, C. Brönnimann, B.M. Frey, C. Gassner	44. Jahreskongress DGTI 27.-30. Sep. 2011 Hannover

	A RARE KEL17/KEL(IVS3+1G>A) COMPOUND HETEROZYGOUS INDIVIDUAL, PRONE TO ANTIKEL11 IMMUNIZATION S. Sigurdardottir, C. Engström, A. Zorbas-Nikos, B.M. Frey, C. Gassner	SVTM Jahreskongress 8.-9. Sep. 2011 Fribourg

	PROGRESS REPORT ON A MALDI-TOF MASS SPECTROMETRY HIGH-THROUGHPUT BLOOD GROUP GENOTYPING PLATFORM C. Gassner, B.M. Frey, C. Vollmer	SVTM Jahreskongress 8.-9. Sep. 2011 Fribourg

	A NAT-ONLY HBV POSITIVE DONATION: BREAKTHROUGH SUBCLINICAL INFECTION IN A HBV VACCINATED BLOOD DONOR? A. Glauser, J. Gottschalk, K. Hardegger, B.M. Frey	SVTM Jahreskongress 8.-9. Sep. 2011 Fribourg

	HIGH-THROUGHPUT BLOOD GROUP GENOTYPING BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY (MALDI-TOF MS), REPORT ON A PROTOTYPE C. Gassner, B.M. Frey, C. Vollmert	XXIInd Regional Congress of the ISBT 18-22 June, 2011 Lisbon

	INVESTIGATION OF BACTERIAL AND VIRAL AGENTS AND IMMUNE STATUS IN BEHCET'S DISEASE PATIENTS FROM IRAN EU Irschick, S. Philipp, F. Shahram, M. Schirmer, M. Sedigh, N. Ziaee, C. Gassner, H. Schennach, M. Meyer, C. Larcher, M. Herold, D. Schoenitzer, D. Fuchs, M. Schoenbauer, M. Maass, HP. Huemer, F. Davatchi	Int. J. of Rheumatic Diseases Vol. 14, Issue 3, 298-310 2011

	EXTENSION OF UPPER AGE LIMIT FOR BLOOD DONATION IS SAFE AND HELPS TO SATISFY THE GROWING NEEDS FOR BLOOD PRODUCTS D. Sinovcic, P. Lodemann, C. Engström, G. Yavuzcan, A. Röthlisberger, B.M. Frey	XXIInd Regional Congress of the ISBT 18-22 June, 2011 Lisbon

	VALIDATION AND IMPLEMENTATION OF THE INTERCEPT BLOOD SYSTEM FOR PLATELETS FOR PATHOGEN INACTIVATION OF APHERESIS AND BUFFY-COAT PRODUCTS AT ONE OF THE BIGGEST REGIONAL BLOOD-CENTERS OF SWITZERLAND D. Goslings, P. Lodemann, G. Yavuzcan, A. Glauser, A. Valek, B.M. Frey	XXIInd Regional Congress of the ISBT 18-22 June, 2011 Lisbon

	FIRST VALIDATION AND IMPLEMENTATION OF THE ORBISAC SYSTEM IN A SWISS BLOOD-CENTER WITHIN THE SCOPE OF INTRODUCINGTHE PATHOGEN INACTIVATION SYSTEM INTERCEPT D. Goslings, A. Valek, B.M. Frey	XXIInd Regional Congress of the ISBT 18-22 June, 2011 Lisbon Poster

	ADVERSE REACTIONS AFTER BLOOD DONATION - RISK PROFILE WITH SPECIAL EMPHASIS ON ELDERLY BLOOD DONORS C. Engström, A. Röthlisberger, B.M. Frey	Swiss Medical Forum Supplement 55 2011;11(18) Poster

	DNA-ALIGNEMENT DRIVEN JAK2 EXON 12 MUTATION ANAYSIS DEFINES 2 BROAD GENETIC MUTANT-"CLUSTER"-VARIANTS AND SIMPLIFIES GENETIC TESTING APPLYING PCR-SSP* S. Sigurdardottir, C. Gassner, E. Meyer, B.M. Frey *Dieser Beitrag wurde von der Schweiz. Gesellschaft für Hämatologie als bestes Abstract 2011 ausgezeichnet.	64. Jahrestagung SGH 11.-13.5.2011 Lausanne

	EXPRESSION OF BLOOD GROUP GENES BY MESENCHYMAL STEM CELLS R. Schäfer, M. Schnaidt, R.A. Klaffschenkel, G. Siegel, M. Schüle, M.A. Rädlein, U. Hermanutz-Klein, M. Ayturan, M. Buadze, C. Gassner, L. Danielyan, T. Kluba, H. Northoff and W.A. Flegel	British Journal of Haematology, 10.1111/j. 1365-2141 February 2011

2010	PROSPECTIVE COMPARISON OF EFFICACY OF THERAPEUTIC APHERESIS VERSUS CONVENTIONAL PHLEBOTOMY - PRELIMINARY DATA FROM HEMOCHROMATOSIS PATIENTS P. Lodemann, J. Ries, G. Schorer, B.M. Frey	Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S25, September 2010

	SEROLOGY HELPS MOLECULARDIAGNOSTICS TO SOLVE A RARE CASE OF HOMOZYGOUS FYX/FYX - CONSEQUENCES FOR TRANSFUSION RECOMMENDATIONS C. Engström, B. Grossrieder, C. Gassner, B.M. Frey	Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S12, September 2010

	FIRST CASE OF HIV WINDOW DONATION IN SWITZERLAND AFTER 8 YEARS OF UNIVERSAL HIV NAT SCREENING J. Gottschalk, Y. Achermann, C. Niederhauser, C. Tinguely, A. Glauser, P. Lodemann, B.M. Frey	Transfusion and Apheresis Science, Vol. 43, Suppl. 1, S25, September 2010 Poster

	COMPLEMENT AS AN ENDOGENOUS ADJUVANT FOR DENDRITIC CELL-MEDIATED INDUCTION OF RETROVIRUS-SPECIFIC CTLS Zoltan Banki, Wilfried Posch, Asim Ejaz, Verena Oberhauser, Suzanne Willey, Christoph Gassner, Heribert Stoiber, Ulf Dittmer, Manfred P. Dierich, Kim J. Hasenkrug, Doris Wilflingseder seit 1/4/2010 bei Blutspende Zürich	PLoS Pathogens, Vol. 6, Issue 4, April 2010

	MULTICENTER STUDY OF THE NEW HIGHLY SENSITIVE AND SPECIFIC ENZYGNOST HBSAG 6.0 ASSAY U. Schobel, T. Dengler, HW. Doerr, JM. Echevarria, WH. Gerlich, J. Gottschalk, M. Graziani, A. Karl, V. Schottstedt, F. Wagner, B. Weber, M. Weik, B. Weissbrich, WR. Willems, S. Nick	Vox Sanguinis Vol. 99, Suppl. 1, July 2010 Abstract

	IRON DEPLETION DYNAMICS AND SAFETY OF THERAPEUTIC ERYTHROCYTAPHERESIS VERSUS CONVENTIONAL PHLEBOTOMY IN PATIENTS WITH HAEMOCHROMATOSIS Peter Lodemann, Judith Ries, Georg Schorer, Beat M. Frey	Vox Sanguinis Vol. 99, Suppl. 1, July 2010 Poster

	PROSOCIAL MOTIVATION AND BLOOD DONATIONS: A SURVEY OF THE EMPIRICAL LITERATURE Lorenz Götte, Alois Stutzer, Beat M. Frey	Transfusion Medicine and Hemotherapy Volume 37, Issue 3, June 2010

	SAFEGUARDS IN BLOOD SUPPLY: A NATIONAL AND EUROPEAN CHALLENGE (EDITORIAL) Beat M. Frey, Peter Schlenke	Transfusion Medicine and Hemotherapy Volume 37, Issue 3, June 2010

	ERHÖHTE INZIDENZ MALIGNER HÄMATOLOGISCHER ERKRANKUNGEN BEI BLUTSPENDERN MIT POSITIVEM DIREKTEN ANTIGLOBULINTEST (DAT) Antje Enekwe, Jutta Theirbach, Barbara Ziegler, Beat M. Frey	Swiss Medical Forum Supplementum 50 2010;10(18) Poster

	ANTI-HLA/PA-ANTIBODIES IN FEMALE BLOOD DONORS DEPEND ON GRAVIDITY STATUS AND REMAIN LIFE-LONG B.M. Frey, Barbara Grossrieder, Antigony Nikos and Peter Lodemann	Swiss Medical Forum Supplementum 50 2010;10(18)

	FORTSCHRITTE IN DER HÄMATOLOGIE B.M. Frey, Urs Nydegger	Pipette Nr. 1, 10-11, 2010

2009	IRON BALANCE IN REPEAT BLOOD DONORS - THE ROLE OF HEPCIDIN G. Schorer, G. Brittenham, R. Darnuzer, M. Westerman, B.M. Frey	Transfusion Medicine and Hemotherapy Vol. 36, Suppl. 1, P 3.05, September 2009 Poster

	ASSOCIATION OF X-LINKED CHRONIC GRANULOMATOUS DISEASE WITH THE RARE MCLEOD PHENOTYPE - A CASE REPORT A. Siderow, J. Ries, B. Grossrieder, J. Reichenbach, R. Seger, M. Hergersberg, B. Röthlisberger, B.M. Frey	Transfusion Medicine and Hemotherapy Vol. 36, Suppl. 1, P 1.16 September 2009 Poster

	FIVE PARAMETER NAT SCREENING BY TAQSCREEN MPX WITH COBAS S201 IN SWITZERLAND: VALIDATION, IMPLEMENTATION AND FIRST EXPERIENCES A. Glauser, K. Hardegger, J. Gottschalk, Beat M. Frey	Transfusion Medicine and Hemotherapy Vol. 36, Suppl. 1, P. 10.04 September 2009 Poster

	WRONG MOLAR HEMOGLOBIN REFERENCE VALUES - A LONGSTANDING ERROR THAT SHOULD BE CORRECTED Peter Lodemann, Georg Schorer, Beat M. Frey	Annals of Hematology: Volume 89, Issue 2 (2010), Page 209

	A PAIR OF NATURALLY OCCURRING ANTIBODIES MAY DAMPEN COMPLEMENT-DEPENDENT PHAGOCYTOSIS OF RED CELLS WITH A POSITIVE ANTIGLOBULIN TEST IN HEALTHY BLOOD DONORS V. Alaia, B.M. Frey, A. Siderow, P. Stammler, M. Kradolfer and H.U. Lutz	Vox Sanguinis (2009) 97, 338-347

	MCLEOD PHENOTYPE ASSOCIATED WITH X-LINKED CHRONIC GRANULOMATOUS DISEASE: A LIAISON WITH SERIOUS CONSEQUENCES A. Siderow, J. Ries, B. Grossrieder, J. Reichenbach, R. Seger, M. Hergersberg and B.M. Frey	Swiss Medical Forum Supplementum 46, P162, 2009;9(18) Poster (212 KB)

	SEQUENTIAL BLOOD DONATION DECREASES TOTAL BODY IRON STORES AND SERUM HEPCIDIN G. Schorer, G. Brittenham, R. Darnuzer, M. Westerman and B.M. Frey	Swiss Medical Forum Supplementum 46, P177, 2009;9(18) Poster (535 KB)

	FOUR PARAMETER NAT SCREENING BY TAQSCREEN MPX WITH COBAS S201 IN SWITZERLAND: VALIDATION, IMPLEMENTATION AND FIRST EXPERIENCES A. Glauser, K. Hardegger, J. Gottschalk and Beat M. Frey	Vox Sanguinis Vol. 96, Suppl. 1, P-111, April 2009 Poster (PDF 53 KB)

	FREE CHOLESTEROL TESTING AS A MOTIVATION DEVICE IN BLOOD DONATIONS: EVIDENCE FROM FIELD EXPERIMENTS Lorenzo Goette, Alois Stutzer, Gürcan Yavuzcan and Beat M. Frey	TRANSFUSION, March 2009, Vol. 49, 524-531

2008	CHARACTERIZATION OF X-CHROMOSOMAL DELETIONS IN TWO PATIENTS WITH MCLEOD SYNDROME BY ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (CGH) M. Hergersberg, C. Ottiger, B.M. Frey, H.H. Jung, J. Reichenbach, R. Seger, B. Udd, J. Bruni, A.R. Huber, B. Röthlisberger	Swiss MedLab, Int. Congress, Montreux, September 16-19, 2008 Poster (PDF 166 KB)

	CHARACTERIZATION OF A 1.7 Mb X-CHROMOSOMAL DELETION IN A PATIENT WITH MCLEOD SYNDROME BY ARRAY CGH M. Hergersberg, B. Röthlisberger, C. Ottiger, B.M. Frey, H.H. Jung, B. Udd, A.R. Huber	19. Jahrestagung der Deutschen Gesellschaft für Humangenetik, 2008 Poster (PDF 166 KB)

2007	SEIZURES OF EXTRATEMPORAL ORIGIN AS A PROMINENT FEATURE IN A TAMILIAN MALE WITH CHOREA-ACANTHOCYTOSIS T. Dorn, B. Bader, A. Danek, H.H. Jung, Y. Achermann, B.M. Frey, G. Krämer	27th Interntl Epilepsy Congress Proceedings. Epilepsia 2007;48,suppl 7:p473 Poster (PDF 111 KB)

	MOLECULAR GENOTYPING OF ANTITHETIC KEL POLYMORPHISMS BY EXON-TARGETING PCR-RFLP Beat M. Frey, Monika Furrer and Pascale Jaquet	Transfusion Medicine and Hemotherapy, Vol.34, Suppl 1, p73 Poster (PDF 85 KB)

	BLOOD DONOR RECRUITMENT: EFFICACY OF VARIOUS INVITATION APPROACHES ON DONOR'S DECISION MAKING O. Ochmann, A. Stutzer, G. Staeheli, L. Götte and B.M Frey	Transfusion Medicine and Hemotherapy, Vol.34, Suppl. 1, p73 Poster (PDF 69 KB)

	MCLEOD SYNDROME - A NEURO-HEMATOLOGICAL DISORDER Hans H. Jung, Adrian Danek and Beat M. Frey	Vox Sanguinis (2007) 93, 112-121 Paper (PDF 259 KB)

	IRON BALANCE IN YOUNG BLOOD DONORS: IS THE LATENT IRON DEFICIENCY SYNDROME (LIDS) UNIVERSAL? Oswin Ochmann, Karin Hardegger and Beat M. Frey	Forum Med. Suisse 2007;7 (Suppl. 35), 73 S Poster (PDF 67 KB)

	THE END OF A DIAGNOSTIC ODYSSEY – A CASE OF CHUVASH POLYCYTHEMIA A. Rüfer, P. Jaquet, WA. Wuillemin and B.M. Frey	Forum Med. Suisse 2007;7 (Suppl. 35), 72 S Poster (PDF 194 KB)

	IRON BALANCE REMAINS STABLE IN LIFE-LONG BLOOD DONORS Beat M. Frey, Axel Rüfer, Karin Hardegger, Gabriela Bachmann, Christine Kuhn, Irène Schmid, Franziska Wägli and Oswin Ochmann	Forum Med. Suisse 2007;7 (Suppl. 35), 78 S Poster (PDF 551 KB)

	PHENOTYPIC VARIABILITY OF A DISTINCT DELETION IN MCLEOD SYNDROME Marcelo Miranda, Claudia Castiglioni, Beat M. Frey, Martin Hergersberg, Adrian Danek and Hans H. Jung	Mov Disord (2007); Vol.22, No.9: 1358-1361

	FREQUENT PLATELET APHERESIS DONATION IN VOLUNTEER DONORS WITH HAEMOGLOBIN <125g/l ARE SAFE AND EFFICIENT Adriana Méndez, Franziska Wägli, Irène Schmid and Beat M. Frey	Transfusion and Apheresis Science (2007) 36, 47-53 Paper (PDF 340 KB)

2006	ALLOCATION OF TRANSFUSION COMPATIBLE RED BLOOD CELL CONCENTRATES IN THE PRESENCE OF WARM-REACTIVE ANTIBODIES – A RETROSPECTIVE COMPARISON OF TWO DIFFERENT STRATEGIES Edi Matheis, Barbara Grossrieder, Anna E. Böhlen-Bodmer, Monika Furrer and Beat M. Frey	Transfusion Medicine and Hemotherapy 2006, Vol. 33 (Suppl. 1), abstr. P6.13, S 46 Poster (PDF 45 KB)

	GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF DOMBROCK (Do) BLOOD GROUP ANTIGENS IN BLOOD DONORS Inga Hegemann, Pascale Jaquet, Monika Furrer and Beat M. Frey	Transfusion Medicine and Hemotherapy 2006, Vol. 33 (Suppl. 1), abstr. P6.15, S 46 Poster (PDF 151 KB)

	COOMBS-POSITIVE RED BLOOD CELLS IN HEALTHY BLOOD DONORS, AN EVIDENCE-BASED EXPLANATION Velia Alaia, Beat Frey, and Hans U. Lutz	Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Hämatologie und Onkologie Leipzig, 2006

	REMAINING RED BLOOD CELL ALLO-ANTIBODIES IN BLOOD PRODUCTS DONATED BY ALLO-SENSITIZED BLOOD DONORS. A COMPARATIVE TITRATION STUDY Edi Matheis, Annelies Böhlen-Bodmer, Barbara Grossrieder and Beat M. Frey	Forum Med Suisse 2006;6: (Suppl 30), 62 S Poster (PDF 92 KB)

	D ANTIGEN DENSITY AND D ZYGOSITY OF REAGENT RED CELLS ARE NOT DETERMINANT FOR ANTI-D SEMIQUANTIFICATION BY STANDARD SEROLOGY TITRATION TECHNIQUES B.M. Frey, N. Dogan, P. Jacquet, M. Furrer	Forum Med Suisse 2006;6: (Suppl 30), 63 S Poster (PDF 28 KB)

	PREVALENCE, SPECIFICITY AND TITER OF ALLO-ANTIBODIES IN VOLONTARY BLOOD DONATIONS AND IN THE CORRESPONDING BLOOD PRODUCTS Beat M Frey, Edi Matheis, A. Böhlen-Bodmer, B. Grossrieder	Vox Sanguinis (2006) 91: Supp.3, P-424 Poster (PDF 99 KB)

	TESTING FOR WEAK D - INTERNATIONAL FORUM C.P. Engelfried, H.W. Reesink, G.F. Körmöczi, W.R. Mayr, S. Panzer, D. Schönitzer, R. Fontao-Wendel, S. Wendel, A. Long, M.H. Dziegiel, V. Kretschmer, R. Karger, F. Morelati, N. Revelli, M.A. Villa, M. Lai, M. de Haas, E. van der Schoot, M. Overbeeke, P. Maaskant, D.Gounder, P. Flanagan, G.B. Solheim, B. Zupanska, M. Lozano, B. Michalewska, E. Muniz-Diaz, C. Martin-Vega, B.M. Frey, A. Mendez, S.A. Kochman, J.S. Epstein, G. Garratty, C. Lomas-Francis, C.M. Westhoff	Vox Sanguinis (2006) 90: 140 - 153

2005	TRANSFUSION OF APHERESIS PLATELETS AND ABO GROUPS - INTERNATIONAL FORUM R.N.I. Pietersz, C.P. Engelfried, H.W. Reesink, K.G. Davis, J. Lown, A. Thomson, P. Turek, E. Dickmeiss, T. Krusius, J. Matilainen, V. Kretschmer, R. Karger, P. Reinhardt, M. Wiesneth, H. Schrezenmeier, E. Seifried, P. Rebulla, N. Greppi, D. Riccardi, F. Molrelati, M. Uchikawa, N.H. Tsuno, K. Takahashi, K. Tadokoro, V.M.J. Novotny, A. Brand, B.G. Solheim, B. Zupanska, M. Lozano, J. Cid, R. Mazzara, F. Knutson, R. Norda, B.M. Frey, S. MacLennan, J.M. Heal, N. Blumberg	Vox Sanguinis (2005) 88: 2007 - 221

	SHOULD WE CHANGE OUR CURRENT PRACTICE OF BLOOD DONOR SCREENING IN SWITZERLAND? THE ALAT DATA Axel Rüfer, Karin Bracher, Adrian Röthlisberger, Gürcan Yavuzcan and Beat M. Frey	Swiss Medical Forum, Suppl. 23, 2005, May 11th, 69s, P200

	PREVALENCE AND SPECIFICITY OF BLOOD GROUP ANTIBODIES IN SWISS BLOOD DONORS Edi Matheis, Annelies Böhlen-Bodmer, Karin Hardegger, Annette Schille and Beat M. Frey	Swiss Medical Forum, Suppl. 23, 2005, May 11th, 70s, P205

	PREVALENCE AND GENOTYPE OF weakD RED BLOOD CELL PHENOTYPES IN SWISS BLOOD DONORS Adriana Méndez, Pascale Jaquet, Karin Hardegger, Annette Schille, Monika Furrer and Beat M. Frey	Swiss Medical Forum, Suppl. 23, 2005, May 11th, 70s, P204

	QUANTIFICATION OF D-ANTIGEN DENSITY OF weakD RED BLOOD CELL PHENOTYPES BY FLOWCYTOMETRY. A RAPID METHOD TO ESTIMATE THE ANTI-D IMMUNIZATION RISK Adriana Méndez, Pascale Jaquet, Monika Furrer and Beat M. Frey	Swiss Medical Forum, Suppl. 23, 2005, May 11th, 22s, abstr. S71

	ASSIGNEMENT OF Lub-NEGATIVITY FOR RARE DONOR SELECTION REQUIRES SOPHISTICATED TECHNIQUES BASED ON MOLECULAR GENOTYPING Christian Rüegg, Adriana Mendez, Edi Matheis, Annelies Böhlen-Bodmer and Beat M. Frey	Swiss Medical Forum, Suppl. 23, 2005, May 11th, 22s, abstr. S72

	COLLECTION OF SINGLE DONOR PLATELET CONCENTRATES BY TRIMA ACCEL, COBE/SPECTRA AND AMICUS CRESCENDO DEVICES: A LARGE, PROSPECTIVE-RANDOMIZED, COMPARATIVE-CROSSOVER STUDY Dagmar Matz, Fränzi Wägli, Ulrike Murer, Monika Furrer and Beat M. Frey	Swiss Medical Forum, Suppl. 23, 2005, May 11th, 71s, P207

2004	SIGNIFICANCE OF CONFIRMATORY TESTING OF BLOOD DONORS WITH POSITIVE SCREENING FINDINGS FOR ANTI-HIV AND ANTI-HCV A. Mendez, A. Rüfer and B.M Frey	Swiss Medical Forum, Suppl 17, 2004; 4: S36, abstr. 239

	UNIVERSAL LEUKODEPLETION OF BLOOD PRODUCTS IN SWITZERLAND: A RETROSPECTIVE ANALYSIS OF QUALITY ASSURANCE DATA Beat M. Frey, E. Skalsky, M. Frey-Wettstein	Swiss Medical Forum, Suppl 17, 2004; 4: S91, abstr. 536

	DIE ENTWICKLUNG DER TRANSFUSIONSMEDIZIN IN DER SCHWEIZ VOM ZWEITEN WELTKRIEG BIS 2003 M. Frey-Wettstein	Transfus Med Hemother 2004; 31(suppl 2): 86-94

2003	MCLEOD PHENOTYPE ASSOCIATED WITH A XK MISSENSE MUTATION WITHOUT HEMATOLOGICAL, NEUROMUSCULAR, or CEREBRAL INVOLVEMENT H.H. Jung, M. Hergersberg, M. Vogt, J. Pahnke, V. Treyer, S.S. Kollias, D.Russo, and B.M. Frey	Transfusion, 2003; Vol 43: 928-38

	ENUMERATION OF RESIDUAL CELLS IN LEUKODEPLETED BLOOD PRODUCTS – TECHNIQUES AND PITFALLS Beat M. Frey and Monika Furrer-Burger	in “Universal Leucodepletion: the European experience” by U. Rossi and R.Garcia de Villaescusa Edizioni SIMTI, Milano, 2003, pp. 105-116

	HISTORY OF BLOOD FILTRATION Manuel Frey-Wettstein	in “Universal Leucodepletion: the European experience” by U. Rossi and R.Garcia de Villaescusa Edizioni SIMTI, Milano, 2003, pp. 3-8

	THE PRESENT SITUATION AND FUTURE DEVELOPMENTS OF UNIVERSAL LEUCODEPLETION IN EUROPE Manuel Frey-Wettstein	in “UniversalL eucodepletion: the European experience” by U. Rossi and R.Garcia de Villaescusa Edizioni SIMTI, Milano, 2003, pp. 167-168

	CHRONIC PLATELET APHERESIS DONATION OF VOLUNTEER DONORS WITH HB <125 G/L IS SAVE AND EFFICIENT Adriana Mendez, Beat M. Frey	Swiss Medical Forum, Suppl 12, 2003, Mai 7, 70s, abstr. 432

	HCV-RNA SCREENING OF SWISS BLOOD DONORS IS REDUNDANT TO ESTABLISHED SURROGATE MARKER TESTING Martin Siroky, Andreas Glauser, Sonja Rosamilia, Beat M. Frey	Swiss Medical Forum, Suppl 12, 2003, Mai 7, 35s, abstr. 205

2002	REPRODUCIBLE QUANTIFICATION OF RESIDUAL WHITE BLOOD CELLS IN LEUKODEPLETED BLOOD PRODUCTS BY FLOWCYTOMETRY OVER MORE THAN 5 DAYS Beat M. Frey, Monika Furrer, Manuel Frey-Wettstein	Swiss Medical Forum Suppl 8, 2002, April 10, 64S, abstr. 344

	COOMBS-POSTIVE RED BLOOD CELLS OF HEALTHY BLOOD DONORS CARRY ANTI-C3/C3B NATURALLY OCCURRING ANTIBODIES (NAbs) Violla Ankelmann¹, Beat M. Frey¹, M. Vogt¹, Rita Eggmann², Claudia Janda², Ivan Galimberti², Hans U. Lutz² ¹Stiftung Zürcher Blutspendedienst SRK, ²Institute of Biochemistry, Swiss Federal Institute of Technology, ETH-Zentrum, 8092 Zürich	Swiss Medical Forum Suppl 8, 2002, April 10, 64S, abstr. 342

	THE G1016A XK MISSENSE MUTATION CAUSES McLEOD IMMUNOPHENOTYPE WITHOUT SYSTEMIC INVOLVEMENT B.M. Frey*, M. Furrer, M. Vogt, Regional Blood Transfusion Service SRC, Zürich; M. Hergersberg, Department of Molecular Biology, Cantonal Hospital, Aarau; V. Treyer, S. Kollias, H.H. Jung, University Hospital Zürich, Switzerland	27^th Congress of the International Society of Blood Transfusion (ISBT), August 24 - 28, 2002, Vancouver, BC

2001	QUALITY CONTROL OF BLOOD COMPONENT PRODUCTS BY FLOWCYTOMETRY Beat M. Frey, Monika Furrer, Manuel Frey-Wettstein	Swiss Medical Forum Suppl 2, 2001, April 25, 71S, abstr. 345

	QUANTIFICATION OF RESIDUAL RED BLOOD CELLS IN PLATELET CONCENTRATES AND FRESH FROZEN PLASMA BY FLOWCYTOMETRY Beat M. Frey, Ursina Minder, Monika Furrer, Manuel Frey-Wettstein	Swiss Medical Forum Suppl 2, 2001, April 25, 71S, abstr. 344

	LARGE VOLUME LEUCOCYTAPHERESIS FOR AUTOLOGOUS PROGENITOR CELL HARVESTING PERFORMED IN A MULTI-INSTITUTIONAL TRANSPLANTATION PROGRAM: FIRST RESULTS AND FUTURE DIRECTIONS B.M. Frey¹, A. Buser¹, M. Frey-Wettstein¹, A. Tobler², K. Zbären², E. Ischi², A. von Rohr³, Th. Von Briel³, H. Gattiker⁴, V. Hofmann⁴, U. Breitenstein⁴, U. Huber⁴, A. Messner⁴, J. Gmür⁴ ¹Stiftung Zürcher Blutspendedienst SRK, Zürich; ²Hämatologisches Zentrallabor, Inselspital, Bern; Onkozentrum ³Hirslanden und ⁴Klinik Im Park, Zürich	Swiss Medical Forum Suppl 2, 2001, April 25, 64S, abstr. 319

2000	HCV-SCREENING VON BLUTSPENDEN MIT SIMULTANER PCR/ELISA TECHNIK ERMÖGLICHT "STATE-OF-THE-ART" SCREENING VON ALLEN ZUR TRANSFUSION FREIGEGEBENEN LABILEN UND STABILEN BLUTPRODUKTEN OHNE VERZÖGERUNG DER PRODUKTFREIGABE. B.M. Frey¹, G. Yavuzcan¹, S. Rosamilia¹, A. Glauser², M. Frey-Wettstein¹ ¹Stiftung Zürcher Blutspendedienst SRK, Hirschengraben 60, CH-8001 Zürich/Switzerland ²Phoenix International (ANAWA), Wangen/Zürich	Schweiz Med Wochenschr, 2000; 130: Suppl 115: 44S

1999	TEMPERATURE CONTROL OF BLOOD COMPONENTS DURING TRANSPORTATION. C. Fritsch, M. Frey-Wettstein, B.M. Frey	VI Regional European Congress of Blood Transfusion (ISBT), Jerusalem, May 9-13, 1999

	SCREENING FOR HCV BY SIMULTANEOUS PCR-/ELISA TECHNIQUES: STATE-OF-THE-ART TESTING OF LABILE AND STABILE BLOOD PRODUCTS PRIOR TO TRANSFUSION. B.M. Frey¹, G. Yavuzcan¹, S. Rosamilia¹, A. Glauser², M. Frey-Wettstein¹ ¹Stiftung Zürcher Blutspendedienst SRK, Hirschengraben 60, CH-8001 Zürich/Switzerland ²Phoenix International (ANAWA), Wangen/Zürich	52^nd Annual Meeting of the American Association of Blood Banks (AABB), San Francisco, Nov 6-10, 1999

	SINGLE DONOR PLATELET CONCENTRATES (SDPC) COLLECTED BY AMICUS, COBE/SPECTRA AND MCS3P APHERESIS DEVICES COMPLY VARIABLY WITH ECONOMICAL AND REGULATORY REQUIREMENTS FOR PRODUCTION OF HIGH QUALITY APHERESIS PRODUCTS. B.M. Frey, S. Rosamilia, A. Buser, I. Schmid, M. Frey-Wettstein	52^nd Annual Meeting of the American Association of Blood Banks (AABB), San Francisco, Nov 6-10, 1999

1998	SINGLE DONOR PLATELET CONCENTRATES (SDPC) COLLECTED FROM VOLUNTEER APHERESIS DONORS (VAD) IN AN ENVIRONMENT OF INCREASING ECONOMICAL AND REGULATORY PRESSURES - IMPACT ON THE BLOOD CENTER'S SUPPLY PROGRAM. B.M. Frey, S. Rosamilia, A. Buser, I. Schmid and M. Frey-Wettstein	Infusionsther Transfusionsmed 1998; 25(Suppl 1): 40

	EFFIZIENTE TRANSGEN-ÜBERTRAGUNG IN HÄMATOPOIETISCHE VORLÄUFER- UND CD34+ STAMMZELLEN MITTELS NEUEM ADENOVEKTOR. B.M. Frey^1,4, S. Rafii², R.G. Crystal³, und M.A.S. Moore¹, ¹Memorial Sloan-Kettering Cancer Center, ²Departement of Hematology/Oncology, ³Departement of Pulmonary and Critical Care Medicine, The New York Hospital/Cornell Medical Center, New York und ⁴Stiftung Zürcher Blutspendedienst SRK	Schweiz Med Wochenschr 1998; 128: Suppl 96, 63S

	ADENOVIRALE LANGZEIT-EXPRESSION VON THROMBOPOIETIN IN VIVO: EIN NEUES MODELL FÜR MYELOPROLIFERATIVES SYNDROM UND OSTEOMYELOFIBROSE.* B.M. Frey^1,4, S. Rafii², R.G. Crystal³, und M.A.S. Moore¹ ¹Memorial Sloan-Kettering Cancer Center, ²Departement of Hematology/Oncology, ³Departement of Pulmonary and Critical Care Medicine, The New York Hospital/Cornell Medical Center, New York und ⁴Stiftung Zürcher Blutspendedienst SR *Diese Beitrag wurde von der Schweiz. Gesellschaft für Hämatologie als bestes Abstract 1998 ausgezeichnet.	Schweiz Med Wochenschr 1998; 128: 1587-1592